An Act To Encourage Alternative Forms of Treatment for Opiate or Opioid Addiction by Prohibiting MaineCare Coverage for Medication-assisted Treatment for Addiction

Sec. 1. 22 MRSA §3174-SS,  as enacted by PL 2011, c. 477, Pt. I, §1, is amended by adding at the end a new paragraph to read:

This section is repealed January 1, 2015.

Sec. 2. 22 MRSA §3174-VV,  as reallocated by RR 2011, c. 2, §27, is amended by adding at the end a new paragraph to read:

This section is repealed January 1, 2015.

Sec. 3. 22 MRSA §3174-WW  is enacted to read:

§ 3174-WW.  Termination of coverage or reimbursement for addiction

summary

Current law limits to 24 months MaineCare coverage or reimbursement for buprenorphine and naloxone combination drugs, also known as Suboxone, for the treatment of addiction to opioids and for methadone for the treatment of addiction to opiates.

This bill, beginning January 1, 2015, prohibits all MaineCare coverage or reimbursement for Suboxone and methadone for treatment of addiction to opioids and opiates, respectively.